GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Interest Expense

Aptamer Group (LSE:APTA) Interest Expense : £-0.12 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Aptamer Group's interest expense for the six months ended in Dec. 2023 was £ -0.04 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.12 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Aptamer Group's Operating Income for the six months ended in Dec. 2023 was £ -1.87 Mil. Aptamer Group's Interest Expense for the six months ended in Dec. 2023 was £ -0.04 Mil. Aptamer Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Aptamer Group Interest Expense Historical Data

The historical data trend for Aptamer Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Interest Expense Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23
Interest Expense
-0.01 -0.01 -0.05 -0.13

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23
Interest Expense Get a 7-Day Free Trial -0.02 -0.02 -0.06 -0.08 -0.04

Aptamer Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptamer Group  (LSE:APTA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aptamer Group's Interest Expense for the six months ended in Dec. 2023 was £-0.04 Mil. Its Operating Income for the six months ended in Dec. 2023 was £-1.87 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was £0.64 Mil.

Aptamer Group's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Aptamer Group did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Aptamer Group (LSE:APTA) Business Description

Traded in Other Exchanges
N/A
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines